Jacksonville, FL - Data from a pharmacodynamic study suggests that acute coronary syndrome (ACS) patients can be safely switched from maintenance clopidogrel (Plavix, Bristol-Myers ...
Two P2Y12 inhibitors often used interchangeably, ticagrelor and prasugrel (antiplatelet medications prescribed to prevent the formation of blood clots), had different impacts on outcomes in patients ...
When choosing a P2Y12 inhibitor to use in combination with aspirin in patients with diabetes undergoing percutaneous coronary intervention (PCI) for multivessel disease, prasugrel may be preferable to ...
Please provide your email address to receive an email when new articles are posted on . In patients with diabetes and multivessel coronary artery disease who had PCI, ticagrelor was not noninferior to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results